
### [NCIT:C3850](http://purl.obolibrary.org/obo/NCIT_C3850)
**Label:** Pancreatic Carcinoma

**Subclasses:** [NCIT:C5723](http://purl.obolibrary.org/obo/NCIT_C5723) (Undifferentiated Pancreatic Carcinoma with Osteoclast-Like Giant Cells), [NCIT:C6879](http://purl.obolibrary.org/obo/NCIT_C6879) (Mixed Ductal-Neuroendocrine Carcinoma of the Pancreas), [NCIT:C5724](http://purl.obolibrary.org/obo/NCIT_C5724) (Pancreatic Serous Cystadenocarcinoma), [NCIT:C7626](http://purl.obolibrary.org/obo/NCIT_C7626) (Recurrent Pancreatic Carcinoma), [NCIT:C6878](http://purl.obolibrary.org/obo/NCIT_C6878) (Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas), [NCIT:C5726](http://purl.obolibrary.org/obo/NCIT_C5726) (Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma), [NCIT:C8933](http://purl.obolibrary.org/obo/NCIT_C8933) (Metastatic Pancreatic Adenocarcinoma), [NCIT:C5720](http://purl.obolibrary.org/obo/NCIT_C5720) (Pancreatic Signet Ring Cell Carcinoma), [NCIT:C7787](http://purl.obolibrary.org/obo/NCIT_C7787) (Stage III Pancreatic Cancer AJCC v6 and v7), [NCIT:C134930](http://purl.obolibrary.org/obo/NCIT_C134930) (Stage IV Pancreatic Cancer AJCC v8), [NCIT:C5721](http://purl.obolibrary.org/obo/NCIT_C5721) (Pancreatic Adenosquamous Carcinoma), [NCIT:C5722](http://purl.obolibrary.org/obo/NCIT_C5722) (Undifferentiated Pancreatic Carcinoma), [NCIT:C95466](http://purl.obolibrary.org/obo/NCIT_C95466) (Pancreatic Medullary Carcinoma), [NCIT:C95465](http://purl.obolibrary.org/obo/NCIT_C95465) (Pancreatic Hepatoid Adenocarcinoma), [NCIT:C7786](http://purl.obolibrary.org/obo/NCIT_C7786) (Stage II Pancreatic Cancer AJCC v6 and v7), [NCIT:C7785](http://purl.obolibrary.org/obo/NCIT_C7785) (Stage I Pancreatic Cancer AJCC v6 and v7), [NCIT:C45843](http://purl.obolibrary.org/obo/NCIT_C45843) (Pancreatic Carcinoma with Mixed Differentiation), [NCIT:C95460](http://purl.obolibrary.org/obo/NCIT_C95460) (Mixed Acinar-Neuroendocrine-Ductal Carcinoma of the Pancreas), [NCIT:C95507](http://purl.obolibrary.org/obo/NCIT_C95507) (Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma), [NCIT:C95428](http://purl.obolibrary.org/obo/NCIT_C95428) (Pancreatic Poorly Differentiated Ductal Adenocarcinoma), [NCIT:C95427](http://purl.obolibrary.org/obo/NCIT_C95427) (Pancreatic Moderately Differentiated Ductal Adenocarcinoma), [NCIT:C95426](http://purl.obolibrary.org/obo/NCIT_C95426) (Pancreatic Well Differentiated Ductal Adenocarcinoma), [NCIT:C134914](http://purl.obolibrary.org/obo/NCIT_C134914) (Stage 0 Pancreatic Cancer AJCC v8), [NCIT:C5727](http://purl.obolibrary.org/obo/NCIT_C5727) (Pancreatic Acinar Cell Cystadenocarcinoma), [NCIT:C37214](http://purl.obolibrary.org/obo/NCIT_C37214) (Colloid Carcinoma of the Pancreas), [NCIT:C5729](http://purl.obolibrary.org/obo/NCIT_C5729) (Stage 0 Pancreatic Cancer AJCC v6 and v7), [NCIT:C134915](http://purl.obolibrary.org/obo/NCIT_C134915) (Stage I Pancreatic Cancer AJCC v8), [NCIT:C134921](http://purl.obolibrary.org/obo/NCIT_C134921) (Stage II Pancreatic Cancer AJCC v8), [NCIT:C7977](http://purl.obolibrary.org/obo/NCIT_C7977) (Pancreatic Acinar Cell Carcinoma), [NCIT:C5711](http://purl.obolibrary.org/obo/NCIT_C5711) (Stage IV Pancreatic Cancer AJCC v6 and v7), [NCIT:C3874](http://purl.obolibrary.org/obo/NCIT_C3874) (Pancreatic Cystadenocarcinoma), [NCIT:C43298](http://purl.obolibrary.org/obo/NCIT_C43298) (Hereditary Pancreatic Carcinoma), [NCIT:C8294](http://purl.obolibrary.org/obo/NCIT_C8294) (Pancreatic Adenocarcinoma), [NCIT:C9120](http://purl.obolibrary.org/obo/NCIT_C9120) (Pancreatic Ductal Adenocarcinoma), [NCIT:C134909](http://purl.obolibrary.org/obo/NCIT_C134909) (Pancreatic Cancer by AJCC v8 Stage), [NCIT:C95458](http://purl.obolibrary.org/obo/NCIT_C95458) (Mixed Acinar-Ductal Carcinoma of the Pancreas), [NCIT:C134902](http://purl.obolibrary.org/obo/NCIT_C134902) (Pancreatic Cancer by AJCC v6 and v7 Stage), [NCIT:C134928](http://purl.obolibrary.org/obo/NCIT_C134928) (Stage III Pancreatic Cancer AJCC v8), 

**Class expressions from DL-Learner:**

- Thing 52.77%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39833](http://purl.obolibrary.org/obo/NCIT_C39833) (Schistosoma Hematobium-Related Bladder Verrucous Carcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39829](http://purl.obolibrary.org/obo/NCIT_C39829) (Infiltrating Bladder Urothelial Carcinoma with Giant Cells))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39826](http://purl.obolibrary.org/obo/NCIT_C39826) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39825](http://purl.obolibrary.org/obo/NCIT_C39825) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39821](http://purl.obolibrary.org/obo/NCIT_C39821) (Infiltrating Bladder Lymphoepithelioma-Like Carcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39820](http://purl.obolibrary.org/obo/NCIT_C39820) (Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39819](http://purl.obolibrary.org/obo/NCIT_C39819) (Infiltrating Bladder Urothelial Carcinoma, Nested Variant))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39818](http://purl.obolibrary.org/obo/NCIT_C39818) (Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39817](http://purl.obolibrary.org/obo/NCIT_C39817) (Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39816](http://purl.obolibrary.org/obo/NCIT_C39816) (Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39815](http://purl.obolibrary.org/obo/NCIT_C39815) (Cellular Congenital Mesoblastic Nephroma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39814](http://purl.obolibrary.org/obo/NCIT_C39814) (Classic Congenital Mesoblastic Nephroma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39813](http://purl.obolibrary.org/obo/NCIT_C39813) (SMARCB1 Gene Inactivation))) 39.52%


